Largest analysis of hydroxychloroquine use finds no benefit for coronavirus, increased deaths

That drug that Trump has been recommending everybody take against coronavirus isn’t doing so well in testing. It’s almost like Trump has no medical experience whatsoever besides knowing the best way to snort Adderall.

An anti-malaria drug touted by President Trump as a potential “game changer” amid the coronavirus outbreak showed no benefit for patients, according to an analysis of those hospitalized in Veterans Health Administration medical centers.

The analysis found the two primary outcomes for COVID-19 patients treated with hydroxychloroquine were death and the need for mechanical ventilation.

The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed coronavirus infections in all Veterans Health Administration medical centers until April 11.

The study analyzed only 368 patients but represented the largest look at the outcomes of COVID-19 patients treated with hydroxychloroquine — with or without azithromycin, a common antibiotic — anywhere in the world.